(Press-News.org) An experimental “decoy” provided long-term protection from infection by the pandemic virus in mice, a new study finds.
Led by researchers at NYU Grossman School of Medicine, the work is based on how the virus that causes COVID-19, SARS-CoV-2, uses its spike protein to attach to a protein on the surface of the cells that line human lungs. Once attached to this cell surface protein, called angiotensin converting enzyme 2 (ACE2), the virus spike pulls the cell close, enabling the virus to enter the cell and hijack its machinery to make viral copies.
Earlier in the pandemic, pharmaceutical companies designed monoclonal antibodies to glom onto the spike and neutralize the virus. Treatment of patients soon after infection was successful in preventing hospitalization and death. However the virus rapidly evolved through random genetic changes (mutations) that altered the spike’s shape enough to evade even combinations of therapeutic monoclonal antibodies. Thus, such antibodies, which neutralized early variants, became about 300 times less effective against more recent delta and omicron variants.
Published online this week in the Proceedings of the National Academy of Sciences, the study describes an alternative approach from which the virus cannot escape. It employs a version of ACE2, the surface protein to which the virus attaches, which, unlike the natural, cell-bound version, is untethered from the cell surface. The free-floating “decoy” binds to the virus by its spikes so that it can no longer attach to ACE2 on cells in airways. Unlike the monoclonal antibodies, which are shaped to interfere with a certain spike shape, the decoy mimics the spike’s main target, and the virus cannot easily evolve away from binding to ACE2 and still invade cells.
Treatment with the decoy, either by injection or droplets in the nose, protected 100 percent of the study mice when they were infected in the lab with an otherwise lethal dose of SARS-CoV-2. The decoy lowered the virus load in the mice by 100,000-fold, while mice exposed to a non-active control treatment died. Decoy treatment of mice that were already infected with SARS-CoV-2 caused a rapid drop in viral levels and return to health. This suggests that the decoy could be effective as a therapy post-infection, similar to monoclonal antibodies, the researchers say.
“What is remarkable about our study is that we delivered the decoy using a harmless, adeno-associated virus or AAV vector, a type of gene therapy that has been found in previous studies to be safe for use in humans,” says senior study author Nathanial Landau, PhD, professor in the Department of Microbiology at NYU Langone Health. “The viral vector instructs cells in the body to produce the decoy so that the mouse or person is protected long-term, without the need for continual treatment.” Administered with the vector, says Landau, the treatment caused cells, not only to make the decoy, but to continue making it for several months, and potentially for years.
Importantly, vaccines traditionally include harmless parts of a virus they are meant to protect against, which trigger a protective immune response should a person later be exposed. Vaccines are less effective, however, if a person’s immune system has been compromised, by diseases like cancer or in transplant patients treated with drugs that suppress the immune response to vaccination. Decoy approaches could be very valuable for immunocompromised patients globally, adds Landau.
For the new study, the research team made key changes to a free ACE2 receptor molecule, and then fused the spike-binding part of it to the tail end of an antibody with the goal of strengthening its antiviral effect. Attaching ACE2 to the antibody fragment to form what the team calls an “ACE2 microbody” increases the time that the molecule persists in tissues (its half-life). The combination also causes the molecules to form dimers, mirror-image molecular pairs that increase the strength with which the decoy attaches to the viral spike.
Whether administered via injection into muscle, or through droplets in the nasal cavity, the study’s AAV vectors provided mice with long-lasting protection COVID infection, including the current Omicron variants.
The approach promises to be effective even if another coronavirus, a type of virus common in birds and bats or apes, were to be transferred to humans in the future, an event termed “zoonosis.” As long as the future virus also uses ACE2 to target cells, the decoy would be ready for “off-the-shelf” soon after an outbreak. If the virus were to somehow switch its receptor a different protein on the surface of lung cells, the decoy could be modified to target the new virus, says Landau.
Along with Landau, the study authors were Takuya Tada and Julia Minnee in the Department of Microbiology at NYU Grossman School of Medicine. The study was supported by a grant from the National Institutes of Health.
Experimental decoy protects against SARS-CoV-2 infection
ELSE PRESS RELEASES FROM THIS DATE:
Light conveyed by the signal transmitting molecule sucrose controls growth of plant roots
Plant growth is driven by light and supplied with energy through photosynthesis by green leaves. It is the same for roots that grow in the dark – they receive the products of photosynthesis, in particular sucrose, i.e. sugar, via the central transportation pathways of phloem. Dr. Stefan Kircher and Prof. Dr. Peter Schopfer from the University of Freiburg’s Faculty of Biology have now shown in experiments using the model plant Arabidopsis thaliana (thale cress) that the sucrose not only guarantees the supply of carbohydrates to the roots, it also acts as a signal transmitter for ...
Mitigating climate change through restoration of coastal ecosystems
One of the primary drivers of climate change is excess greenhouse gases like carbon dioxide in the atmosphere. Mitigating climate change in the coming century will require both decarbonization — electrifying the power grid or reducing fossil fuel-guzzling transportation — and removing already existing carbon dioxide from the atmosphere, a process called carbon dioxide removal. Researchers at the Georgia Institute of Technology and Yale University are proposing a novel pathway through which coastal ecosystem restoration can permanently capture carbon dioxide from the atmosphere. Seagrass and mangroves — known as blue carbon ecosystems — naturally capture ...
Flexible nanoelectrodes can provide fine-grained brain stimulation
HOUSTON – (May 30, 2023) – Conventional implantable medical devices designed for brain stimulation are often too rigid and bulky for what is one of the body’s softest and most delicate tissues. To address the problem, Rice University engineers have developed minimally invasive, ultraflexible nanoelectrodes that could serve as an implanted platform for administering long-term, high-resolution stimulation therapy. According to a study published in Cell Reports, the tiny implantable devices formed stable, long-lasting and seamless tissue-electrode ...
Teens with irregular sleep patterns have higher risk of school problems
DARIEN, IL – A new study to be presented at SLEEP 2023 found that teens with greater variability in their sleep patterns have a higher risk for school-related problems. Results show that the teens with greater night-to-night variability in the time they fell asleep were 42% more likely to have been suspended or expelled in the past two years, 29% more likely to have received a D or F in any course, and 26% more likely to have ever failed a course. The likelihood of suspension or expulsion was also 31% higher in teens with greater variability in sleep duration. “Variability in sleep duration and later sleep ...
Genetic risk information may help people avoid alcohol addiction
Today’s substance use prevention efforts ignore individual genetic risk, but Rutgers research suggests DNA test results may eventually enhance prevention and treatment and improve outcomes. Investigators recruited 325 college students, provided them with varying levels of information about alcohol use disorder and how genetics affect addiction risk and asked them how they would react to learning they had high, medium and low genetic tendencies toward alcoholism. The results provided two significant supports for eventually using real genetic risk scores in actual addiction prevention efforts. First, participants understood what those scores indicated; they recognized that higher ...
Advances in technology are driving popularity of EVs
Transportation accounts for roughly one-third of U.S. greenhouse gas emissions, and adoption of electric vehicles are seen by many experts in government and the private sector as a vital tool in efforts to reduce carbon emissions. Roughly a decade ago, EVs accounted for a tiny fraction of overall car sales. As of March 2023, they make up 7% of new sales “What changed between then and now?” asks Kenneth Gillingham, professor of environmental and energy economics at the Yale School of the Environment. ...
Newborns with higher hair cortisol levels take longer to fall asleep
DARIEN, IL – Cortisol levels in late pregnancy can predict the sleep of infants, according to a new study to be presented at the SLEEP 2023 annual meeting. Results show that newborns with higher levels of cortisol in their hair samples took longer to fall asleep at 7 months of age. Neonatal hair cortisol is a measure of fetal cortisol in the last trimester of pregnancy. “Although increases in cortisol across pregnancy are normal and important for preparing the fetus for birth, our findings ...
That’s not nuts: Almond milk yogurt packs an overall greater nutritional punch than dairy-based
May 30, 2023 That’s Not Nuts: Almond Milk Yogurt Packs an Overall Greater Nutritional Punch than Dairy-Based UMass Amherst food science major completes comparison of 612 plant-based and dairy yogurts AMHERST, Mass. – In a nutritional comparison of plant-based and dairy yogurts, almond milk yogurt came out on top, according to research led by a University of Massachusetts Amherst food science major. “Plant-based yogurts overall have less total sugar, less sodium and more fiber than dairy, but they have less protein, calcium and potassium than dairy yogurt,” ...
Using AI to create better, more potent medicines
COLUMBUS, Ohio – While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly accelerate the drug-development process. Today, most drug discovery is carried out by human chemists who rely on their knowledge and experience to select and synthesize the right molecules needed to become the safe and efficient medicines we depend on. To identify the synthesis paths, scientists often employ a technique called retrosynthesis – a method for creating potential drugs by working backward from the wanted molecules and searching for chemical reactions ...
Quest for alien signals in the heart of the Milky Way takes off
May 30, 2023, Mountain View, CA – Akshay Suresh, a graduate student at Cornell University, spearheads an extraordinary scientific endeavor -- a groundbreaking mission to uncover periodic signals emanating from the core of the Milky Way called the Breakthrough Listen Investigation for Periodic Spectral Signals (BLIPSS). Such repetitive patterns could be the key to unlocking the mysteries of extraterrestrial intelligence in our galaxy. Suresh and his co-authors detail the project’s results thus far in a paper accepted for publication in the Astronomical Journal, “A 4–8 GHz Galactic Center Search for Periodic Technosignatures.” BLIPSS ...